CVE:GSD Devonian Health Group (GSD) Stock Price, News & Analysis C$0.15 0.00 (0.00%) As of 07/28/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Devonian Health Group Stock (CVE:GSD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Devonian Health Group alerts:Sign Up Key Stats Today's RangeC$0.15▼C$0.1550-Day RangeC$0.11▼C$0.1952-Week RangeC$0.08▼C$0.35Volume1,400 shsAverage Volume17,120 shsMarket CapitalizationC$22.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada. Read More Receive GSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address GSD Stock News HeadlinesDevonian Health Group Secures $2.27 Million in Private PlacementAugust 7 at 8:44 PM | tipranks.comDevonian Health Group Reports Third Quarter 2025 Financial ResultsJune 26, 2025 | financialpost.comFGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.August 8 at 2:00 AM | Priority Gold (Ad)Devonian Health Group Reports Second Quarter 2025 Financial ResultsApril 15, 2025 | financialpost.comFDevonian Health Group Faces Cease Trade Order Amid Filing DelaysApril 14, 2025 | tipranks.comDevonian Health Group Reports Cease Trade OrderApril 14, 2025 | financialpost.comFDevonian Health Group Delays Financial Reporting Due to Restatement NeedsApril 1, 2025 | tipranks.comDevonian Reports Delay of Financial ReportingApril 1, 2025 | financialpost.comFSee More Headlines GSD Stock Analysis - Frequently Asked Questions How have GSD shares performed this year? Devonian Health Group's stock was trading at C$0.16 at the beginning of the year. Since then, GSD shares have decreased by 6.3% and is now trading at C$0.15. How do I buy shares of Devonian Health Group? Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryComputer Software Current SymbolCVE:GSD CIKN/A Webwww.groupedevonian.com Phone450-937-6696FaxN/AEmployees6Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$3.17 million Net Margins-32.50% Pretax MarginN/A Return on Equity-23.31% Return on Assets-8.12% Debt Debt-to-Equity Ratio16.36 Current Ratio1.07 Quick Ratio7.82 Sales & Book Value Annual SalesC$9.75 million Price / Sales2.28 Cash FlowC$0.02 per share Price / Cash Flow6.10 Book ValueC$0.09 per share Price / Book1.67Miscellaneous Outstanding Shares148,220,000Free FloatN/AMarket CapC$22.23 million OptionableNot Optionable Beta1.28 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (CVE:GSD) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Devonian Health Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Devonian Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
